Dr. Reddy's Laboratories
RDY
#1699
Rank
C$16.39 B
Marketcap
C$19.60
Share price
0.35%
Change (1 day)
-4.31%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$2.79 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total liabilities are C$2.79 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dr. Reddy's Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31C$2.62 B51.22%
2024-03-31C$1.73 B15.96%
2023-03-31C$1.49 B-11.17%
2022-03-31C$1.68 B6.18%
2021-03-31C$1.58 B9.87%
2020-03-31C$1.44 B-11.88%
2019-03-31C$1.63 B-16.55%
2018-03-31C$1.96 B-0.09%
2017-03-31C$1.96 B26.36%
2016-03-31C$1.55 B-8.49%
2015-03-31C$1.69 B16.16%
2014-03-31C$1.46 B12.25%
2013-03-31C$1.30 B6.99%
2012-03-31C$1.21 B13.94%
2011-03-31C$1.06 B26.41%
2010-03-31C$0.84 B-18.59%
2009-03-31C$1.03 B7.23%
2008-03-31C$0.96 B-18.67%
2007-03-31C$1.19 B-2.61%
2006-03-31C$1.22 B426.03%
2005-03-31C$0.23 B37.98%
2004-03-31C$0.16 B28.48%
2003-03-31C$0.13 B14.5%
2002-03-31C$0.11 B-48.71%
2001-03-31C$0.22 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
C$159.74 B 5,609.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$45.03 B 1,509.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$84.66 B 2,926.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
C$86.39 B 2,987.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$91.21 B 3,160.23%๐Ÿ‡ซ๐Ÿ‡ท France